Global Prenatal and Newborn Genetic Testing Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Prenatal and Newborn Genetic Testing Revenue
• 1.4 Market by Type
  • 1.4.1 Global Prenatal and Newborn Genetic Testing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Array-Comparative Genetic Hybridization (aCGH)
  • 1.4.3 Fluorescence In-Situ Hybridization (FISH)
  • 1.4.4 Polymerase Chain Reaction (PCR)
• 1.5 Market by Application
  • 1.5.1 Global Prenatal and Newborn Genetic Testing Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Diagnostic Organization
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Prenatal and Newborn Genetic Testing Market Perspective (2015-2026)
• 2.2 Global Prenatal and Newborn Genetic Testing Growth Trends by Regions
  • 2.2.1 Prenatal and Newborn Genetic Testing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Prenatal and Newborn Genetic Testing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Prenatal and Newborn Genetic Testing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Prenatal and Newborn Genetic Testing Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Prenatal and Newborn Genetic Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Prenatal and Newborn Genetic Testing Players by Market Size
  • 3.1.1 Global Top Prenatal and Newborn Genetic Testing Players by Revenue (2015-2020)
  • 3.1.2 Global Prenatal and Newborn Genetic Testing Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Prenatal and Newborn Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Prenatal and Newborn Genetic Testing Market Concentration Ratio
  • 3.2.1 Global Prenatal and Newborn Genetic Testing Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Prenatal and Newborn Genetic Testing Revenue in 2019
• 3.3 Prenatal and Newborn Genetic Testing Key Players Head office and Area Served
• 3.4 Key Players Prenatal and Newborn Genetic Testing Product Solution and Service
• 3.5 Date of Enter into Prenatal and Newborn Genetic Testing Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Prenatal and Newborn Genetic Testing Historic Market Size by Type (2015-2020)
• 4.2 Global Prenatal and Newborn Genetic Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020)
• 5.2 Global Prenatal and Newborn Genetic Testing Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Prenatal and Newborn Genetic Testing Market Size (2015-2020)
• 6.2 Prenatal and Newborn Genetic Testing Key Players in North America (2019-2020)
• 6.3 North America Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020)
• 6.4 North America Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Prenatal and Newborn Genetic Testing Market Size (2015-2020)
• 7.2 Prenatal and Newborn Genetic Testing Key Players in Europe (2019-2020)
• 7.3 Europe Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020)
• 7.4 Europe Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020)

8 China

• 8.1 China Prenatal and Newborn Genetic Testing Market Size (2015-2020)
• 8.2 Prenatal and Newborn Genetic Testing Key Players in China (2019-2020)
• 8.3 China Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020)
• 8.4 China Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Prenatal and Newborn Genetic Testing Market Size (2015-2020)
• 9.2 Prenatal and Newborn Genetic Testing Key Players in Japan (2019-2020)
• 9.3 Japan Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020)
• 9.4 Japan Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Prenatal and Newborn Genetic Testing Market Size (2015-2020)
• 10.2 Prenatal and Newborn Genetic Testing Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020)
• 10.4 Southeast Asia Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020)

11 India

• 11.1 India Prenatal and Newborn Genetic Testing Market Size (2015-2020)
• 11.2 Prenatal and Newborn Genetic Testing Key Players in India (2019-2020)
• 11.3 India Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020)
• 11.4 India Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Prenatal and Newborn Genetic Testing Market Size (2015-2020)
• 12.2 Prenatal and Newborn Genetic Testing Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Prenatal and Newborn Genetic Testing Market Size by Type (2015-2020)
• 12.4 Central & South America Prenatal and Newborn Genetic Testing Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Roche Diagnostic
  • 13.1.1 Roche Diagnostic Company Details
  • 13.1.2 Roche Diagnostic Business Overview
  • 13.1.3 Roche Diagnostic Prenatal and Newborn Genetic Testing Introduction
  • 13.1.4 Roche Diagnostic Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020))
  • 13.1.5 Roche Diagnostic Recent Development
• 13.2 Elitech Group
  • 13.2.1 Elitech Group Company Details
  • 13.2.2 Elitech Group Business Overview
  • 13.2.3 Elitech Group Prenatal and Newborn Genetic Testing Introduction
  • 13.2.4 Elitech Group Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
  • 13.2.5 Elitech Group Recent Development
• 13.3 Myriad Genetics
  • 13.3.1 Myriad Genetics Company Details
  • 13.3.2 Myriad Genetics Business Overview
  • 13.3.3 Myriad Genetics Prenatal and Newborn Genetic Testing Introduction
  • 13.3.4 Myriad Genetics Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
  • 13.3.5 Myriad Genetics Recent Development
• 13.4 Biocartis
  • 13.4.1 Biocartis Company Details
  • 13.4.2 Biocartis Business Overview
  • 13.4.3 Biocartis Prenatal and Newborn Genetic Testing Introduction
  • 13.4.4 Biocartis Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
  • 13.4.5 Biocartis Recent Development
• 13.5 IntegraGen
  • 13.5.1 IntegraGen Company Details
  • 13.5.2 IntegraGen Business Overview
  • 13.5.3 IntegraGen Prenatal and Newborn Genetic Testing Introduction
  • 13.5.4 IntegraGen Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
  • 13.5.5 IntegraGen Recent Development
• 13.6 Perkin Elmer
  • 13.6.1 Perkin Elmer Company Details
  • 13.6.2 Perkin Elmer Business Overview
  • 13.6.3 Perkin Elmer Prenatal and Newborn Genetic Testing Introduction
  • 13.6.4 Perkin Elmer Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
  • 13.6.5 Perkin Elmer Recent Development
• 13.7 WaferGen Biosystem
  • 13.7.1 WaferGen Biosystem Company Details
  • 13.7.2 WaferGen Biosystem Business Overview
  • 13.7.3 WaferGen Biosystem Prenatal and Newborn Genetic Testing Introduction
  • 13.7.4 WaferGen Biosystem Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
  • 13.7.5 WaferGen Biosystem Recent Development
• 13.8 Interpace Diagnostics
  • 13.8.1 Interpace Diagnostics Company Details
  • 13.8.2 Interpace Diagnostics Business Overview
  • 13.8.3 Interpace Diagnostics Prenatal and Newborn Genetic Testing Introduction
  • 13.8.4 Interpace Diagnostics Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
  • 13.8.5 Interpace Diagnostics Recent Development
• 13.9 Quest Diagnostic
  • 13.9.1 Quest Diagnostic Company Details
  • 13.9.2 Quest Diagnostic Business Overview
  • 13.9.3 Quest Diagnostic Prenatal and Newborn Genetic Testing Introduction
  • 13.9.4 Quest Diagnostic Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
  • 13.9.5 Quest Diagnostic Recent Development
• 13.10 Bio-Rad
  • 13.10.1 Bio-Rad Company Details
  • 13.10.2 Bio-Rad Business Overview
  • 13.10.3 Bio-Rad Prenatal and Newborn Genetic Testing Introduction
  • 13.10.4 Bio-Rad Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
  • 13.10.5 Bio-Rad Recent Development
• 13.11 AutoGenomics
  • 10.11.1 AutoGenomics Company Details
  • 10.11.2 AutoGenomics Business Overview
  • 10.11.3 AutoGenomics Prenatal and Newborn Genetic Testing Introduction
  • 10.11.4 AutoGenomics Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
  • 10.11.5 AutoGenomics Recent Development
• 13.12 Abbott
  • 10.12.1 Abbott Company Details
  • 10.12.2 Abbott Business Overview
  • 10.12.3 Abbott Prenatal and Newborn Genetic Testing Introduction
  • 10.12.4 Abbott Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
  • 10.12.5 Abbott Recent Development
• 13.13 Cepheid
  • 10.13.1 Cepheid Company Details
  • 10.13.2 Cepheid Business Overview
  • 10.13.3 Cepheid Prenatal and Newborn Genetic Testing Introduction
  • 10.13.4 Cepheid Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
  • 10.13.5 Cepheid Recent Development
• 13.14 EKF Diagnostics
  • 10.14.1 EKF Diagnostics Company Details
  • 10.14.2 EKF Diagnostics Business Overview
  • 10.14.3 EKF Diagnostics Prenatal and Newborn Genetic Testing Introduction
  • 10.14.4 EKF Diagnostics Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
  • 10.14.5 EKF Diagnostics Recent Development
• 13.15 Natera
  • 10.15.1 Natera Company Details
  • 10.15.2 Natera Business Overview
  • 10.15.3 Natera Prenatal and Newborn Genetic Testing Introduction
  • 10.15.4 Natera Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
  • 10.15.5 Natera Recent Development
• 13.16 Agilent Technologies
  • 10.16.1 Agilent Technologies Company Details
  • 10.16.2 Agilent Technologies Business Overview
  • 10.16.3 Agilent Technologies Prenatal and Newborn Genetic Testing Introduction
  • 10.16.4 Agilent Technologies Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
  • 10.16.5 Agilent Technologies Recent Development
• 13.17 Illumina
  • 10.17.1 Illumina Company Details
  • 10.17.2 Illumina Business Overview
  • 10.17.3 Illumina Prenatal and Newborn Genetic Testing Introduction
  • 10.17.4 Illumina Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
  • 10.17.5 Illumina Recent Development
• 13.18 Ariosa Diagnostics
  • 10.18.1 Ariosa Diagnostics Company Details
  • 10.18.2 Ariosa Diagnostics Business Overview
  • 10.18.3 Ariosa Diagnostics Prenatal and Newborn Genetic Testing Introduction
  • 10.18.4 Ariosa Diagnostics Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
  • 10.18.5 Ariosa Diagnostics Recent Development
• 13.19 Sequenom
  • 10.19.1 Sequenom Company Details
  • 10.19.2 Sequenom Business Overview
  • 10.19.3 Sequenom Prenatal and Newborn Genetic Testing Introduction
  • 10.19.4 Sequenom Revenue in Prenatal and Newborn Genetic Testing Business (2015-2020)
  • 10.19.5 Sequenom Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer